Get Our FREE Newsletter

Sign Up

Agilent (A) Expands pharmDX Assay Use in the European Union

Spread the love

Agilent Technologies A has bolstered presence in the clinical and diagnostic testing market of Europe by expanding the use of its PD-L1 IHC 22C3 pharmDx assay in patients suffering from non-small cell lung cancer (NSCLC) in the European Union.The assay will enable patholo

This post was originally published on this site